sb.scorecardresearch
Advertisement

Published 17:18 IST, July 11th 2020

Biocon’s drug Itolizumab gets DCGI Nod for treatment of moderate to severe COVID patients

Biocon's breakthrough drug Itolizumab is one of the first biologic therapy drugs to be approved for the treatment of COVID patients across the world

Reported by: Ananya Varma
Follow: Google News Icon
  • share
COVID-19
null | Image: self
Advertisement

17:12 IST, July 11th 2020